HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, today announced its entry into the patient care market in Taiwan with the launch of DUROLANE®, a single-injection joint-fluid osteoarthritis (OA) treatment based on a natural, safe and proven technology process called NASHA® which yields stabilized hyaluronic acid (HA). “The company’s market coverage, relationships with key opinion leaders, […]